Independent Guidance For Veterans & FamiliesNot Affiliated With The VA

VA BENEFITS REFERENCE

DC 7716: Aplastic Anemia

Read VA diagnostic code 7716 for Aplastic anemia: published criteria, regulatory notes, related codes and official sources checked October 25, 2026.

Independent Education · Official Sources · Last Verified October 25, 2026

Published criteria from 38 CFR 4.117, current through 2026-10-22. Historical decisions may require a different version. This reference does not diagnose a condition or determine an evaluation.

The Hematologic and Lymphatic Systems · All Diagnostic Codes

DC 7716: Aplastic Anemia

Diagnostic code 7716 addresses Aplastic anemia. Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.

Diagnostic Code 7716 - 38 CFR 4.117
Rating
7716 Aplastic anemia:
Requiring peripheral blood or bone marrow stem cell transplant; or requiring transfusion of platelets or red cells, on average, at least once every six weeks per 12-month period; or infections recurring, on average, at least once every six weeks per 12-month period100
Requiring transfusion of platelets or red cells, on average, at least once every three months per 12-month period; or infections recurring, on average, at least once every three months per 12-month period; or using continuous therapy with immunosuppressive agent or newer platelet stimulating factors60
Requiring transfusion of platelets or red cells, on average, at least once per 12-month period; or infections recurring, on average, at least once per 12-month period30
Note (1): A 100 percent evaluation for peripheral blood or bone marrow stem cell transplant shall be assigned as of the date of hospital admission and shall continue with a mandatory VA examination six months following hospital discharge. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter
Note (2): The term “newer platelet stimulating factors” includes medication, factors, or other agents approved by the United States Food and Drug Administration

What The Criteria Measure

  • Does the decision identify diagnostic code 7716, and does the medical record describe the condition named by this code?
  • Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
  • Have the code-specific notes and cross-references been read before comparing any listed evaluation?

Related Public DBQs

Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.

Shared Rules And Regulatory Context

Context provisions do not create an additional evaluation automatically assigned to every condition.

Related Guides

Official Sources

Last verified 2026-10-25. Source publication or legal effective dates are shown separately where available.

Check The Source. Get Accredited Help.

Use this resource to understand published information. VA and the official decision control individual benefits.